Arca
Skip to content

Onetouch Ultra, Induo And Ultrasmart Blood Glucose Monitoring System

Glucose Oxidase, Glucose. 510(k) K043197, from Lifescan, Inc. (Milpitas, CA). Product code CGA, class 2.

As of Nov 18, 2026, K043197 is an FDA 510(k) held by Lifescan, Inc., substantially equivalent on May 20, 2005 after 183 days, with 3 recalls tied to it in FDA's recall database.

  • Substantially equivalent: May 20, 2005
  • Review time: 183 days
  • Recalls: 3
  • Cited as a predicate by: 3 devices

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The OneTouch® Ultra® Blood Glucose Monitoring System is intended to be used for quantitative measurement of glucose in fresh capillary whole blood. The OneTouch® Ultra® System is intended for use outside the body (in vitro diagnostic use) by people with diabetes at home and healthcare professionals in a clinical setting as an aid to monitor the effectiveness of diabetes control.

Cited as a Predicate

3 later 510(k) summaries name this device as a predicate

Recalls

Recalls FDA ties to K043197, newest first; each opens FDA's recall record
Nov 1, 2005Z-0435-06Product may be defective and may give low inaccurate glucose results.Terminated
Oct 19, 2005Z-0273-06Vials of OneTouch Ultra Test Strips marked with quantities of 25 per vial actually contain only 10 strips.Terminated
Oct 10, 2005Z-0272-06Users may inadvertently change units of measurement on demonstration kits of the OneTouch Ultra Blood Glucose MetersTerminated

Other CGA Clearances

The newest 510(k)s for the same product code; their median review was 270 days; see every CGA device

Record

Type
Traditional
Received
Nov 18, 2004
Review panel
Clinical Chemistry
Regulation
21 CFR 862.1345

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.